scispace - formally typeset
L

Luisa Imberti

Researcher at Canadian Real Estate Association

Publications -  163
Citations -  8354

Luisa Imberti is an academic researcher from Canadian Real Estate Association. The author has contributed to research in topics: T cell & Medicine. The author has an hindex of 30, co-authored 141 publications receiving 5215 citations.

Papers
More filters
Journal ArticleDOI

MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patients.

TL;DR: It is found that, at the individual-patient level, the response to IFN β therapy was extremely heterogeneous, including patients with stable or transitory, early or late loss of IFNβ bioactivity, and patients with samples lacking MxA mRNA induction in spite of absence of antibodies, and these data warrant the quantification of M xA mRNA as a primary tool for a routine monitoring ofIFNβ therapy.
Journal ArticleDOI

Evidence for antigenic selection of large granular lymphocytes in a patient with Wiskott-Aldrich syndrome.

TL;DR: A common pattern of junctional diversity associated with different TCRBV segments is consistent with a strong on-going antigenic selection process, possibly related to the pathogenesis of Wiskott-Aldrich syndrome.
Journal ArticleDOI

Prognostic value of serum/plasma neurofilament light chain for COVID‐19‐associated mortality

TL;DR: Increased levels of circulating neurofilament light chain (NfL), a biomarker of neuronal injury, have been observed in severe COVID‐19 patients and it is investigated whether NfL provides non‐redundant clinical value to previously identified predictors of CO VID‐19 mortality.
Journal ArticleDOI

Neonatal T4+ lymphocytes: analysis of the expression of 4B4 and 2H4 antigens.

TL;DR: The findings suggest that the relative immunoincompetence observed in the newborn may result from a variety of mechanisms including a low percentage of helper-inducer (4B4+2H4-) T4+ lymphocytes possibly also associated to an increased number of suppressor-inducer T4+, as well as a high percentage of T 4+ cord blood cells that can coexpress both antigens.